Drug Discovery & Development | Twice-daily pill could turn leukemia into a highly treatable disease Medical Xpress What's more, just 13 percent of patients treated with rituximab alone responded to the therapy, compared to 81 percent of the participants in the idelalisib treatment group. A higher percentage of patients who received both drugs – some 92 percent ... New pill can 'melt away' leukemia without chemotherapy A Pill 'Melts Away' Common Form of Leukemia |
